BL Pharmtech Corp. (KOSDAQ:065170)

BL Pharmtech Statistics

Total Valuation

BL Pharmtech has a market cap or net worth of KRW 66.56 billion. The enterprise value is 64.49 billion.

Market Cap	66.56B
Enterprise Value	64.49B

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

BL Pharmtech has 27.91 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	27.91M
Shares Outstanding	27.91M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.85%
Owned by Insiders (%)	26.15%
Owned by Institutions (%)	n/a
Float	20.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.23
PB Ratio	8.40
P/TBV Ratio	8.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.84
EV / Sales	9.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.64.

Current Ratio	0.95
Quick Ratio	0.88
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.26

Financial Efficiency

Return on equity (ROE) is -104.28% and return on invested capital (ROIC) is -13.34%.

Return on Equity (ROE)	-104.28%
Return on Assets (ROA)	-4.65%
Return on Invested Capital (ROIC)	-13.34%
Return on Capital Employed (ROCE)	-22.09%
Weighted Average Cost of Capital (WACC)	22.33%
Revenue Per Employee	542.14M
Profits Per Employee	-1.40B
Employee Count	12
Asset Turnover	0.24
Inventory Turnover	2.63

Taxes

In the past 12 months, BL Pharmtech has paid 5.94 million in taxes.

Income Tax	5.94M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +140.48% in the last 52 weeks. The beta is 3.40, so BL Pharmtech's price volatility has been higher than the market average.

Beta (5Y)	3.40
52-Week Price Change	+140.48%
50-Day Moving Average	3,816.60
200-Day Moving Average	1,516.74
Relative Strength Index (RSI)	34.96
Average Volume (20 Days)	1,595,084

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BL Pharmtech had revenue of KRW 6.51 billion and -16.78 billion in losses. Loss per share was -629.00.

Revenue	6.51B
Gross Profit	3.69B
Operating Income	-2.03B
Pretax Income	-16.78B
Net Income	-16.78B
EBITDA	-1.48B
EBIT	-2.03B
Loss Per Share	-629.00

Balance Sheet

The company has 7.15 billion in cash and 5.04 billion in debt, with a net cash position of 2.11 billion or 75.59 per share.

Cash & Cash Equivalents	7.15B
Total Debt	5.04B
Net Cash	2.11B
Net Cash Per Share	75.59
Equity (Book Value)	7.93B
Book Value Per Share	292.69
Working Capital	-410.36M

Cash Flow

Operating Cash Flow	-283.76M
Capital Expenditures	n/a
Depreciation & Amortization	556.32M
Net Borrowing	-3.03B
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 56.74%, with operating and profit margins of -31.24% and -257.89%.

Gross Margin	56.74%
Operating Margin	-31.24%
Pretax Margin	-257.94%
Profit Margin	-257.89%
EBITDA Margin	-22.69%
EBIT Margin	-31.24%
FCF Margin	n/a

Dividends & Yields

BL Pharmtech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-25.20%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 26, 2025. It was a forward split with a ratio of 3.

Last Split Date	Feb 26, 2025
Split Type	Forward
Split Ratio	3

Scores

BL Pharmtech has an Altman Z-Score of -6.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.42
Piotroski F-Score	2